United States

Hercules Capital Inc (HTGC.N)

HTGC.N on New York Stock Exchange

4:02pm EDT
Change (% chg)

$0.03 (+0.21%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for HTGC.N


Hercules Capital, Inc. is a specialty finance company. The Company is an internally managed, non-diversified, closed-end investment company. The Company focuses on providing senior secured venture growth loans to venture capital-backed companies in a range of technology, life sciences, and sustainable and renewable technology... (more)


Beta: 0.87
Market Cap(Mil.): $1,211.24
Shares Outstanding(Mil.): 82.79
Dividend: 0.31
Yield (%): 8.48


  HTGC.N Industry Sector
P/E (TTM): 16.16 6.14 20.13
EPS (TTM): 0.91 -- --
ROI: 5.00 0.82 0.40
ROE: 8.96 1.26 15.48

BRIEF-Xoma announces full repayment of Hercules Technology Growth Capital debt obligation

* Xoma announces full repayment of hercules technology growth capital debt obligation

Mar 22 2017

BRIEF-Hercules Capital to benefit from Federal Reserve benchmark interest rate

* Hercules Capital's highly asset sensitive debt investment portfolio to generate additional $0.02 of net investment income earnings annually(1) from the recent increase in the federal reserve benchmark interest rate

Mar 16 2017

BRIEF-Hercules Capital Q4 non-gaap operating EPS $0.45

* Hercules announces fourth quarter NII per share of $0.43, record full-year 2016 financial results and quarterly distribution of $0.31 per share

Feb 23 2017

BRIEF-Axovant sciences announces $55.0 mln venture debt financing from Hercules Capital

* Axovant sciences announces $55.0 million venture debt financing from Hercules Capital

Feb 03 2017

BRIEF-Hercules Capital announces offering of $150 mln convertible senior notes

* Hercules Capital announces offering of $150.0 million convertible senior notes

Jan 18 2017

BRIEF-Hercules announces earnings per share $0.32

* Hercules announces strong third quarter financial results with $0.32 nii per share and a $0.31 quarterly dividend Source text for Eikon: Further company coverage:

Nov 03 2016

BRIEF-Acelrx Pharma says amended loan and security deal with Hercules Tech II and Hercules Capital Inc

* Among other things, amendment extends interest-only period from October 1, 2016 to April 1, 2017 - SEC filing

Oct 03 2016

More From Around the Web

Earnings vs. Estimates